Fidelity Value Factor ETF (NYSEARCA:FVAL – Get Free Report)’s share price reached a new 52-week high on Thursday . The stock traded as high as $83.64 and last traded at $83.6610, with a volume of 18778 shares changing hands. The stock had previously closed at $82.79.
Fidelity Value Factor ETF Trading Down 0.6%
The business has a fifty day simple moving average of $80.95 and a two-hundred day simple moving average of $76.91. The stock has a market cap of $1.37 billion, a PE ratio of 19.06 and a beta of 0.95.
Institutional Investors Weigh In On Fidelity Value Factor ETF
Several hedge funds have recently made changes to their positions in FVAL. Northwestern Mutual Wealth Management Co. lifted its position in Fidelity Value Factor ETF by 3,648.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 113,362 shares of the company’s stock valued at $8,193,000 after buying an additional 110,338 shares during the period. Diversify Wealth Management LLC bought a new position in shares of Fidelity Value Factor ETF in the 1st quarter worth about $899,000. Beacon Advisors Holdings LLC purchased a new position in Fidelity Value Factor ETF during the 4th quarter valued at about $13,819,000. Dynamic Advisor Solutions LLC lifted its position in Fidelity Value Factor ETF by 12.3% during the 2nd quarter. Dynamic Advisor Solutions LLC now owns 331,727 shares of the company’s stock valued at $25,853,000 after acquiring an additional 36,428 shares during the period. Finally, Storen Legacy Partners LLC bought a new stake in Fidelity Value Factor ETF during the fourth quarter worth about $484,000.
Fidelity Value Factor ETF Company Profile
The Fidelity Value Factor ETF (FVAL) is an exchange-traded fund that is based on the Fidelity U.S. Value Factor index. The fund follows a fundamentally selected, tier-weighted index of large-cap US stocks. FVAL was launched on Sep 12, 2016 and is managed by Fidelity.
Read More
- Five stocks we like better than Fidelity Value Factor ETF
- Lululemon’s Earnings Beat Hid a Bigger Problem for Its Turnaround Story
- MarketBeat Week in Review – 08/31 – 09/04
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
Receive News & Ratings for Fidelity Value Factor ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fidelity Value Factor ETF and related companies with MarketBeat.com's FREE daily email newsletter.
